Filing Details

Accession Number:
0001267602-15-000072
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2015-11-16 16:15:36
Reporting Period:
2015-04-30
Filing Date:
2015-11-16
Accepted Time:
2015-11-16 16:15:36
Original Submission Date:
2015-05-04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1267602 Alimera Sciences Inc ALIM Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1489533 Daniel C. Myers 6120 Windward Parkway, Suite 290
Alpharetta GA 30005
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-04-30 678 $3.71 90,995 No 5 A Direct
Common Stock Disposition 2015-05-01 2,000 $4.37 88,995 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 A Direct
No 4 S Direct
Footnotes
  1. These shares were acquired under the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d).
  2. The Form 4 initially filed on May 4, 2015 inadvertently reported an incorrect number of shares acquired under the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan and thus the number of shares beneficially owned following the transaction was also incorrect.
  3. The Form 4 initially filed on May 4, 2015 inadvertently listed an incorrect price.
  4. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2014.